Cagrilintide is an investigational, long-acting amylin analog designed for weight management, showing significant results in clinical trials by reducing appetite and slowing gastric emptying. As a once-weekly subcutaneous injection, it is often paired with semaglutide (CagriSema) for enhanced weight loss and glycemic control.
Key Aspects of Cagrilintide:
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 12PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
Glucagon-like peptide-2 (GLP2-T) is a 33-amino acid peptide hormone secreted by intestinal L-cells that…
"GLP-3" is a term often used to describe investigational triple-agonist drugs, most notably retatrutide…
Glucagon-like peptide-1 (GLP-1) is a natural gut hormone released after meals that regulates blood…
